Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1998
03/17/1998CA1339760C Antihypertensive hyperimmine milk, prodiction, composition, and use
03/17/1998CA1339759C Stable bioactive somatotropins
03/17/1998CA1339758C Human reg protein
03/17/1998CA1339757C Production of purified biologically active, bacterially produced recombinant human csf-1
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/17/1998CA1339736C Method for preparing fusion proteins
03/17/1998CA1339735C Cloning and sequencing of the major outer capsid gylcoprotein gene of a human rotavirus
03/17/1998CA1339734C Bacillus thuringiensis transformation
03/17/1998CA1339733C Cis-acting repression sequences, cis-acting anti-repression sequences vectors, methods of preparation and use
03/17/1998CA1339732C Synthesis and immunogenicity of rotavirus genes using baculovirus expression system
03/17/1998CA1339731C Multiplex genomic dna amplification for deletion detection
03/17/1998CA1339730C Monoclonal antibiodies and methods for fungal pathogen detection
03/17/1998CA1339729C Human papillomavirus type 52 dna sequences and methods for employing thesame
03/13/1998CA2215084A1 Cytoplasmic male sterility dna factor and utilization thereof
03/12/1998WO1998010291A1 Biochemical markers of the human endometrium
03/12/1998WO1998010287A1 A screening assay for thrombin receptor antagonists
03/12/1998WO1998010102A2 Multi-resistant bacteria, methods for obtaining them and their uses
03/12/1998WO1998010090A1 Gata-6 transcription factor: compositions and methods
03/12/1998WO1998010087A1 Chimpanzee adenovirus vectors
03/12/1998WO1998010086A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998WO1998010083A1 Herpesvirus saimiri as viral vector
03/12/1998WO1998010081A2 Improved barstar-gene
03/12/1998WO1998010080A1 Salt-inducible promoter derivable from a lactic acid bacterium, and its use in a lactic acid bacterium for production of a desired protein
03/12/1998WO1998010079A1 A lactic acid bacterial regulatable expression system
03/12/1998WO1998010076A2 Phospholipase d and dna sequences
03/12/1998WO1998010072A1 INTERFERON-η INDUCING FACTOR IN NEUROENDOCRINE CELLS
03/12/1998WO1998010071A1 Angiogenic factor and use thereof in treating cardiovascular disease
03/12/1998WO1998010070A1 HUMANIZED IMMUNOGLOBULIN REACTING SPECIFICALLY WITH Fas LIGAND OR ACTIVE FRAGMENTS THEREOF AND REGION INDUCING APOPTOSIS ORIGINATING IN Fas LIGAND
03/12/1998WO1998010069A2 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF
03/12/1998WO1998010068A2 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998WO1998010067A1 Human homolog of the latheo gene
03/12/1998WO1998010066A1 Modulators of brca1 activity
03/12/1998WO1998010065A1 Breast carcinoma-associated gene
03/12/1998WO1998010064A1 Iron regulated promoter and uses thereof
03/12/1998WO1998010063A1 Methods for preparing synthetic repetitive dna
03/12/1998WO1998009993A1 Novel protease inhibitors derived from guamerin
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009991A2 Enteric neural peptide
03/12/1998WO1998009990A1 Fungal antigens and process for producing the same
03/12/1998WO1998009981A1 Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009979A1 Lipid metabolic pathway compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009655A1 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009648A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS
03/12/1998WO1998009647A2 Cyanidin compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009646A1 A method for generating birnavirus from synthetic rna transcripts
03/12/1998WO1998009643A1 Modulation of apoptosis by serine phosphorylation of blc-xl/blc-2 associated cell death regulator
03/12/1998WO1998009639A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998WO1998009638A1 INHIBITION OF MAST CELL ACTIVATION BY gp49-BASED MECHANISMS AND REAGENTS
03/12/1998WO1998009602A2 Anti-atherosclerotic peptides and a transgenic mouse model of atherosclerosis
03/12/1998WO1998009524A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors
03/12/1998WO1998009522A1 Insecticidal peptides from segestria sp. spider venom
03/12/1998WO1998009521A1 Dna and encoded protein which regulates cold and dehydration regulated genes
03/12/1998WO1998009510A1 Methods of diagnosing and treating cancer
03/12/1998WO1998009505A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998WO1998005792A3 A novel human leptin receptor gene-related protein
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1998003872A3 Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg
03/12/1998WO1998001563A3 Adenovirus e4 proteins for inducing cell death
03/12/1998WO1998000545A3 G protein signal transduction in plants
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998WO1997046661A3 A human radioresistance/cell cycle progression gene
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998WO1997041895A3 TREATMENT OF ASTHMA WITH TNFR-Ig
03/12/1998WO1997038087A3 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
03/12/1998DE19636889A1 Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel Antineoplastic acting transferrin and albumin conjugates cytostatic compounds from the group of anthracyclines, alkylating agents, antimetabolites and cisplatin analogues and pharmaceutical compositions containing them
03/12/1998CA2639051A1 Fungal antigens and process for producing the same
03/12/1998CA2266190A1 Multi-resistant bacteria, methods for obtaining them and their uses
03/12/1998CA2265889A1 E25a protein, methods for production and use thereof
03/12/1998CA2265883A1 Iron regulated promoter and uses thereof
03/12/1998CA2265470A1 Biochemical markers of the human endometrium
03/12/1998CA2264968A1 Humanized immunoglobulin reacting specifically with fas ligand or active fragments thereof and region inducing apoptosis originating in fas ligand
03/12/1998CA2264965A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998CA2264956A1 Herpesvirus saimiri as viral vector
03/12/1998CA2264845A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264499A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998CA2264493A1 Human homolog of the latheo gene
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264489A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998CA2264486A1 Non-iga fc binding forms of the group b streptococcal beta antigens
03/12/1998CA2264485A1 Gata-6 transcription factor: compositions and methods
03/12/1998CA2259969A1 Phospholipase d and dna sequences
03/12/1998CA2259959A1 Modulators of brca1 activity
03/12/1998CA2236770A1 Salt-inducible promoter derivable from a lactic acid bacterium, and its use in a lactic acid bacterium for production of a desired protein
03/11/1998EP0828005A2 Apoptotic agents for tumor cells of the nervous system
03/11/1998EP0827968A2 Bioactive substance having antitumor activity, producing strain, production ans use thereof
03/11/1998EP0827698A2 Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
03/11/1998EP0827591A1 Method for diagnosing a patient for chlamydia
03/11/1998EP0827547A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
03/11/1998EP0827544A2 Multimeric proteins
03/11/1998EP0827541A1 A method and nucleotide sequence for transforming microorganisms
03/11/1998EP0827540A1 Transgenic animal models for type ii diabetes mellitus
03/11/1998EP0827539A2 Kunitz type protease inhibitors
03/11/1998EP0827538A1 Novel variants of apolipoprotein a-i
03/11/1998EP0827537A2 Chromatin-regulator genes
03/11/1998EP0827513A1 Methods of treatment and diagnostic visualisation, particularly in cancer
1 ... 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 ... 2916